Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Gynecologic Oncology|December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.Japanese Journal of Clinical Oncology|June 1, 2006
Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancerJae Ho Byun, Myung Ah Lee, Sang Young Roh, et al.International Journal of Cancer|September 26, 2006
Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinomaIn Sook Woo, Kyung-Ae Kim, Hae-Myung Jeon, et al.Cancer Chemotherapy and Pharmacology|August 5, 2009
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trialJoung-Soon Jang, Ho Yeong Lim, In Gyu Hwang, et al.Journal for Immunotherapy of Cancer|March 14, 2024
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, et al.Journal of Gastric Cancer|May 2, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical ObservationGuk Jin Lee, Hyunho Kim, Sung Shim Cho, et al.Cancer Chemotherapy and Pharmacology|January 27, 2009
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II studyJeeyun Lee, Kyung Hae Jung, Young Suk Park, et al.Cancer Research and Treatment|April 29, 2016
Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 YearsJi Hyung Hong, Kyung Sun Ha, Yun Hwa Jung, et al.Cancer Medicine|July 30, 2019
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, et al.Therapeutic Advances in Medical Oncology|September 28, 2020
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinomaChanghoon Yoo, Inhwan Hwang, Tae Jun Song, et al.Pageof 21